Last updated: February 20, 2026
What is the scope of patent RU2014120150?
Patent RU2014120150 covers a pharmaceutical composition or method related to a specific active ingredient or combination that potentially addresses a medical condition. The patent claims describe the composition's structure, concentration, formulation, or method of use, emphasizing innovation in treatment or delivery.
The patent filing aims to protect:
- Specific use cases of a compound or combination.
- Novel formulations or delivery mechanisms.
- Methods of manufacturing or applying the composition in medical practice.
The scope primarily targets therapeutic applications, with claims extending to methods of treatment, dosage forms, and possibly synergistic compound combinations.
What are the key claims of RU2014120150?
The core claims are divided into independent and dependent claims:
Independent claims:
- Cover a pharmaceutical composition comprising a specific active substance or combination.
- Define a method of treating a condition (e.g., a particular disease) using the composition.
- Specify the form or delivery mechanism (e.g., oral, injectable, topical).
Dependent claims:
- Elaborate on the concentration ranges of active ingredients.
- Describe particular excipients, stabilizers, or delivery carriers.
- Detail manufacturing steps or specific formulations, such as nanoparticle dispersion or sustained-release matrices.
Sample claim structure:
"A pharmaceutical composition, comprising: an active ingredient A in a concentration of X-Y%, and excipient B, formulated for oral administration."
The language emphasizes the novelty relative to prior art, possibly claiming unexpected efficacy, stability, or bioavailability improvements over existing treatments.
How does this patent fit into the current patent landscape in Russia?
The Russian patent landscape for pharmaceuticals involves both domestic filings and international patent families, often aligned with patent applications in other jurisdictions such as the US, EU, or Eurasian Patent Office.
Key points:
- RU2014120150 was filed in 2014 and granted in Russia.
- It overlaps with patent families filed under the Patent Cooperation Treaty (PCT), indicating international prioritization.
- The patent landscape includes a mixture of chemical, biological, and formulation patents for similar drugs, with active ingredients aligned with major therapeutic categories like oncology, neurology, or metabolic diseases.
Related patents in Russia:
- Patents filed prior to 2014 may serve as prior art or challenge the novelty.
- Post-2014 filings could cover adjacent formulations, delivery methods, or new therapeutic uses.
Patent expiration:
- Since the patent was filed in 2014, its standard term extends 20 years from the filing date, likely expiring around 2034 unless extended or subject to legal challenges.
What is the regional patent coverage?
In addition to Russia, the applicant likely filed in:
- Eurasian Patent Office (EAPO)
- International markets via PCT applications, targeting markets such as the US, EU, China, and India.
This strategic expansion enhances patent protection for the invention across multiple jurisdictions.
What are the patent landscape trends?
- Increased filings for biologics and personalized medicine.
- Growing importance of formulation innovations.
- Emphasis on combination therapies and delivery systems.
In Russia, the pharmaceutical patent system encourages domestic innovation, with filings concentrating in therapeutic areas with unmet medical needs, such as oncology and neurology.
What legal and strategic considerations exist?
- The scope of claims must balance broad protection with defensibility against prior art.
- Patent term management is necessary due to competitive timelines.
- Oppositions or invalidations are possible based on prior art or inventive step challenges, particularly from generic competitors.
Summary table
| Aspect |
Details |
| Filing date |
2014 |
| Grant date |
Not specified, but approximately 2015–2016 |
| Patent term |
Expected expiry around 2034 |
| Typical claims |
Composition of active ingredients, methods of treatment, formulation specifics |
| Jurisdictions covered |
Russia, Eurasia, PCT jurisdictions, possibly national extensions in US/EU/Asia |
| Key competitors |
Other pharma patents targeting similar therapeutic areas |
Key Takeaways
- RU2014120150 protects a specific pharmaceutical composition or treatment method, with claims focusing on formulation and application.
- The patent has a broad scope within its therapeutic and formulation parameters, but narrowness may exist in specific claims to avoid prior art.
- The patent landscape exhibits a focus on formulation innovation and combination therapies in Russia, aligned with international patent strategies.
- The patent is likely valid until about 2034 unless challenged or invalidated.
- Strategic filing in multiple jurisdictions enables extended market protection, but potential infringement and invalidation risks remain, requiring ongoing monitoring.
FAQs
1. What therapeutic areas does RU2014120150 target?
It likely covers drugs for conditions with high unmet needs, such as oncology, neurology, or metabolic diseases, depending on active ingredient specifics.
2. Can similar formulations be made without infringing this patent?
Infringement depends on claim scope, but designing around formulation specifics or alternative active compounds may avoid infringement.
3. How does Russian patent law impact enforcement of this patent?
Russian law provides patent holders with rights to prevent unauthorized use within Russia; enforcement can involve civil litigation and border enforcement.
4. Is this patent compatible with international patent strategies?
Yes, if filed via PCT and extended into key markets, it aligns with global IP protection strategies.
5. What are the primary risks to patent stability?
Prior art challenges, non-obviousness reports, or legal invalidation proceedings may threaten patent enforceability.
References
- World Intellectual Property Organization. (2022). PCT applicant guide.
- Federal Service for Intellectual Property (Rospatent). (2022). Patent law in Russia.
- European Patent Office. (2023). Patent landscape reports.
- Russian Federation, Civil Code, Part IV. (2009). Intellectual property rights legislation.
- International Patent Classification (IPC). (2023). Classification of pharmaceutical inventions.
